Medical Condition News

RSS

Public awareness about the effect of alcohol on cancer risk remains low in the U.S.

Despite clear evidence linking alcohol use to increased cancer risks, public awareness of this connection remains low in the U.S., according to new research from The University of Texas MD Anderson Cancer Center.

30 Oct 2025

Advances in diagnosis and management of systemic light chain amyloidosis

Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin light chains as insoluble amyloid fibrils in various tissues and organs, leading to progressive structural and functional impairment.

30 Oct 2025

New chemotherapeutic agent shows remarkable efficacy against multiple tumor types

A research team led by the Medical University of Vienna, the HUN-REN Research Centre for Natural Sciences and the Eötvös Loránd University in Budapest has developed a groundbreaking new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies.

30 Oct 2025

Therapeutic potential of Scleromitrion diffusum in gastric cancer treatment

Gastric cancer remains a major global health challenge, characterized by high mortality and limited therapeutic efficacy, especially in advanced stages.

30 Oct 2025

Liver alterations associated with MASLD can directly affect the brain and behavior

A multidisciplinary research team has discovered that liver alterations associated with metabolic dysfunction-associated fatty liver disease (MASLD) can directly cause cognitive and neurological impairments, and that these effects can be reversed by a therapy exclusively targeting the liver.

30 Oct 2025

Novel non-invasive laser treatment method for vision defects

Laser treatment every few years and always being able to see clearly without glasses sounds like a dream. Researchers and industry partners are developing the method for turning this into reality.

30 Oct 2025

Understanding the role of m6A methylation in acute lung injury pathogenesis

Acute lung injury (ALI) is a critical clinical condition characterized by diffuse inflammation of the lung parenchyma and intractable hypoxemia, typically caused by factors, such as trauma, pneumonia, shock, and sepsis.

30 Oct 2025

Dance alleviates perceived symptoms of depression, study finds

Dance as a performative art form alleviates perceived symptoms of depression, helps to understand its root causes and promotes self-actualization, a recent study from the University of Eastern Finland found.

30 Oct 2025

Pharmacists can help control blood sugar in cancer patients with diabetes

People with cancer who received diabetes care from clinical pharmacists achieved significantly better blood sugar control, according to new research from the University of California San Diego.

30 Oct 2025

Football hits leave lasting brain changes

Recent MRI research reveals how repeated football head impacts reshape brain structures, offering insights into chronic traumatic encephalopathy (CTE) risk.

30 Oct 2025

Sertraline contributes to a modest improvement in core depression and anxiety symptoms

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major clinical trial led by UCL researchers.

30 Oct 2025

Fundamental challenges and cutting-edge strategies in developing new GBM CAR-T therapies

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under two years, despite standard care involving surgery, radiation, and temozolomide chemotherapy.

30 Oct 2025

Scientists uncover why many cancer patients develop chemotherapy-induced neuropathy

Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve damage after chemotherapy.

30 Oct 2025

Breakthrough could offer a new therapeutic option for stopping diabetes-induced complications

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

30 Oct 2025

Veterans with post-traumatic brain injury epilepsy more likely to have higher mortality rates

Military veterans who develop epilepsy after a traumatic brain injury may have a higher mortality rate in the following years than veterans who develop epilepsy with no previous traumatic brain injury, according to a study published on October 29, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

30 Oct 2025

New study sheds light on vision loss in idiopathic intracranial hypertension

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.

30 Oct 2025

Low-cost biosensor identifies altered protein levels associated with psychiatric disorders

Brazilian researchers have developed a low-cost, portable biosensor that can quickly identify a protein whose altered levels are associated with psychiatric disorders, such as depression, schizophrenia, and bipolar disorder.

30 Oct 2025

Research identifies biomarkers in blood to fine-tune breast cancer interventions

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.

30 Oct 2025

Stem cells show promise in preventing post-heart attack heart failure

Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds a clinical trial published by The BMJ today.

30 Oct 2025

WHO reviews highlight limited long-term data on GLP-1 drug safety

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity.

30 Oct 2025

Previous
1
...
56
57
58
59
60
61
62
...
5819
Next

Medical Condition News

Public awareness about the effect of alcohol on cancer risk remains low in the U.S.

Advances in diagnosis and management of systemic light chain amyloidosis

New chemotherapeutic agent shows remarkable efficacy against multiple tumor types

Therapeutic potential of Scleromitrion diffusum in gastric cancer treatment

Liver alterations associated with MASLD can directly affect the brain and behavior

Novel non-invasive laser treatment method for vision defects

Understanding the role of m6A methylation in acute lung injury pathogenesis

Dance alleviates perceived symptoms of depression, study finds

Pharmacists can help control blood sugar in cancer patients with diabetes

Football hits leave lasting brain changes

Sertraline contributes to a modest improvement in core depression and anxiety symptoms

Fundamental challenges and cutting-edge strategies in developing new GBM CAR-T therapies

Scientists uncover why many cancer patients develop chemotherapy-induced neuropathy

Breakthrough could offer a new therapeutic option for stopping diabetes-induced complications

Veterans with post-traumatic brain injury epilepsy more likely to have higher mortality rates

New study sheds light on vision loss in idiopathic intracranial hypertension

Low-cost biosensor identifies altered protein levels associated with psychiatric disorders

Research identifies biomarkers in blood to fine-tune breast cancer interventions

Stem cells show promise in preventing post-heart attack heart failure

WHO reviews highlight limited long-term data on GLP-1 drug safety

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News